Both in Pharmaceuticals
Xilio Therapeutics vs RenovoRx
Over the past year XLO returned −34.9% and RNXT returned +12.2%; their daily moves had a correlation of -0.08.
XLO −34.9% RNXT +12.2%Growth of $1, one year, split-adjusted
| Metric | XLO | RNXT |
|---|---|---|
| Price | $7.57 | $1.29 |
| Market cap | $49.8M | $58.2M |
| Today | −5.73% | +1.57% |
| 1 month | −15.9% | −23.2% |
| 6 months | −8.9% | +50.6% |
| Year to date | −15.5% | +53.6% |
| 1 year | −28.2% | +14.2% |
| Revenue growth (YoY) | +131.2% | +115.4% |
| Gross margin | 100.0% | 84.3% |
| Net margin | −34.1% | −320.2% |
| P/E (TTM) | — | — |
| Price / sales | 0.8× | 29.5× |
| Net cash | $136.0M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 26.3% | 107.5% |
| Short % of float | 10.3% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).